Back to User profile » Dr Gema Requena
Papers published by Dr Gema Requena:
![Plain language summary](assets/img/article_icons/plain-language.png)
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJ, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2039-2054
Published Date: 15 September 2023
![Plain language summary](assets/img/article_icons/plain-language.png)
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1431-1444
Published Date: 13 July 2023
![Plain language summary](assets/img/article_icons/plain-language.png)
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:643-659
Published Date: 19 April 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:231-245
Published Date: 5 March 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Duarte M, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1781-1795
Published Date: 10 August 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study
Requena G, Dedman D, Quint JK, Ghosh RE, Williams R, Pimenta JM
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:629-642
Published Date: 10 March 2021